Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05435066 · ClinicalTrials.gov registry record
Development and Validation of Harbinger Health Test for Early Cancer Detection
A clinical trial of Cancer, sponsored by Harbinger Health.
- Completed
- Registry status
- 8,038
- Enrollment target
- 20
- Study locations
NCT05435066: Completed study of Cancer, sponsored by Harbinger Health.
NCT05435066 is a study of Cancer that has completed, run by Harbinger Health. The registered enrollment target is 8,038 participants, above the 3,478-participant average among 615 other Cancer trials with a reported enrollment target (131% higher). The trial reports 20 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05435066, a study of Cancer, has completed, sponsored by Harbinger Health.
- COMPLETED
- Registry status
- 8,038 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a prospective, multi-center, observational study with a collection of biospecimens and clinical data from approximately 10,000 participants from up to 125 clinical network sites and locations in the United States. The objective of this study is to collect blood samples, tissue samples, and associated clinical data from participants with a variety of solid tumor and hematologic cancers and non-cancer participants for testing and the development of a screening test for early cancer detection.
Primary Outcome
Analyze Subject's cfDNA from blood samples for "cancer" or "non-cancer" signals using the Harbinger Health test, and compare results of the test to clinical diagnosis
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Harbinger Health Test
Study Locations (20)
Florida
- Central Florida Pulmonary Group - Altamonte Springs - Altamonte Springs
- ENT and Allergy Associates of Florida, LLC - Boca Raton
- Plastic Surgery Specialists of Boca Raton - Boca Raton
- ENT and Allergy Associates of Florida, LLC - Boca Raton
- South Florida Center for Gynecologic Oncology - Boca Raton
- Urology Center of South Florida - Boynton Beach
- Advanced Cancer Surgery and Digestive Health - Boynton Beach
- ENT and Allergy Associates of Florida, LLC - Brandon
California
- Pacific Cancer Medical Center - Anaheim
- Central California ENT Medical Group - Fresno
- South Coast Gynecologic Oncology, Inc - San Diego
- South Coast Gynecologic Oncology, INC - San Diego
- Sansum Clinic - Santa Barbara
- Gynecologic Oncology Associates - Torrance
Alaska
- Alaska Oncology and Hematology, LLC - Anchorage
- Alaska Womens Cancer Care - Anchorage
Alabama
- Southern Cancer Center - Daphne
Arizona
- Arizona Oncology Associates HAL - Prescott Valley
Colorado
- Colorado Primary Health Care - Littleton
Delaware
- Medical Oncology Hematology Consultants, PA - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,038 participants |
| Start Date | 2022-06-21 |
| Est. Completion | 2025-06-11 |
What the finished NCT05435066 record still lists
NCT05435066 is an observational study that tracks outcomes without assigning an intervention. Its 8,038 participants enrollment target places it among the larger protocols in the corpus, above the 3,478-participant average among 615 other Cancer trials with a reported enrollment target (131% higher).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Harbinger Health Test is the first listed.
NCT05435066 names 20 study sites across 7 states, led by Florida, California, Alaska.
Frequently Asked Questions
What is clinical trial NCT05435066 about?
NCT05435066 is a clinical study titled "Development and Validation of Harbinger Health Test for Early Cancer Detection". This is a prospective, multi-center, observational study with a collection of biospecimens and clinical data from approximately 10,000 participants from up to 125 clinical network sites and locations in the United States. The objective of this study is to collect blood samples, tissue samples, and a...
What is the current status of trial NCT05435066?
This trial is currently completed. The enrollment target is 8,038 participants. The study started on 2022-06-21. Estimated completion is 2025-06-11.
What conditions does trial NCT05435066 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT05435066?
The interventions under investigation include: Harbinger Health Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05435066?
This trial is sponsored by Harbinger Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05435066 being conducted?
This trial has 20 study locations across Alabama, Alaska, Arizona, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05435066's enrollment target sits among peer trials
8,038 33rd of 615 higher than 583 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05593484 · 8,060 participants · NA
School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Alaska
- NCT00539162 · 8,000 participants · NA
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
- NCT00898638 · 8,000 participants
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
- NCT02240862 · 8,000 participants
The CREST-2 Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI